Featured content
What will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
ArticleStrategies for scaling complex next-generation biologics
As biologic drug formats grow more sophisticated, scalable success depends on embedding manufacturability, analytics and quality thinking into molecular design from the very beginning of development.
OpinionHow can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.
ArticleRethinking the role of chemotherapy in haematology and oncology – reflections from EHA 2026
As chemotherapy use declines and targeted therapies assume a larger role in cancer treatment, researchers are looking beyond response rates to focus on real-world feasibility and reducing treatment burden for patients.
News
NewsFDA updates drug safety testing rules to embrace non-animal methods
New rule reflects scientific advances where more viable alternatives to animal testing are available, while retaining use of these studies where appropriate.
NewsEnhanced microbial cultivation method bridges transition between native habitats and the lab
Applying the continuous-flow technology enabled domestication of previously uncultured bacteria, addressing a key bottleneck in laboratory microbial cultivation.
NewsBayer’s Kerendia approved in US as first new CKD and type 1 diabetes therapy in three decades
FDA’s latest approval authorises Bayer’s non-steroidal mineralocorticoid receptor antagonist (MRA) Kerendia for a third indication.
NewsSanofi trims mature medicines portfolio and divests of three manufacturing sites
Divestment agreement expands decade-long collaboration between Sanofi and Cheplapharm, helps to hone Sanofi’s innovation focus.
From our Partners
The impact of negative control stability on recombinant endotoxin testing
In this webinar, FUJIFILM Wako Chemicals Europe GmbH will present the results of a study evaluating how NC stability in endotoxin detection reagents affects assay performance.
Opinion and interviews
What will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
How can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Upcoming Webinars
Webinar
Risks of non-compliance: managing impurity control and challenges with reference materials
Join USP to explore the latest approaches to organic impurity analysis and scientific solutions to support pharmaceutical quality, including regulatory expectations and practical applications of the USP Reference Standards.
Webinar
Ensuring drug quality: mastering stability testing in pharma
Join this webinar to discover how UV-Vis spectroscopy and gas chromatography support API monitoring, testing and analysis.
Webinar
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
Join this webinar to discover how modern QA/QC laboratories are embracing digital transformation to enhance compliance, workflows and data integrity to build a more connected, future-ready pharmaceutical quality ecosystem.
Webinar
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
In this webinar, Particle Measuring Systems will share a case study of a biopharmaceutical company developing and applying a structured global rationale for the implementation of continuous viable environmental monitoring with a single-use microbial impactor within aseptic manufacturing environments.
Webinar
The impact of negative control stability on recombinant endotoxin testing
In this webinar, FUJIFILM Wako Chemicals Europe GmbH will present the results of a study evaluating how NC stability in endotoxin detection reagents affects assay performance.
Risks of non-compliance: managing impurity control and challenges with reference materials
Ensuring drug quality: mastering stability testing in pharma
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
The impact of negative control stability on recombinant endotoxin testing
On-demand Webinars
- Previous
- Next
